Table 2

Univariate analysis of disease specific survival and overall survival
Variables Disease-specific survival Overall survival
N HR 95% CI p HR 95% CI p
Age (yrs)
≤ 65 35 1 1
> 65 107 1.88 0.69–5.08 0.21 2.03 0.78–5.25 0.15
Sex
Male 115 1 1
Female 27 1.45 0.47–4.46 0.52 1.3 0.44–3.86 0.63
Tumor grade
Low 11 1 1
High 131 2.97 0.42–20.90 0.27 2.99 0.46–19.58 0.25
Stage
NMIBC 82 1 1
MIBC 60 11.78 4.71–29.43 <0.0001 8.83 3.65–21.32 0.0015
Combined immunostaining score for CXCL1
None / Low 34 1 1
Moderate 53 3.45 0.84–14.13 0.085 2.68 0.76–9.50 0.13
High 55 5.73 1.92–17.10 0.0018 4.63 1.60–13.37 0.0047

Abbreviations: HR Hazard ratio, 95% CI 95% confidence interval, NMIBC Non-muscle invasive bladder cancer, MIBC Muscle invasive bladder cancer.

Miyake et al.

Miyake et al. BMC Cancer 2013 13:322   doi:10.1186/1471-2407-13-322

Open Data